Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

Ozempic could be behind a “concerning” return of skinny models, the editor of British Vogue magazine has said. Chioma Nnadi ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

Regulatory watchdog South African Health Products Regulatory Authority said these types of products pose a health risk to the public.

GLP-1 agonists – of which Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide) are the most ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

If you said diabetes, you're right -- a new study finds diabetes costs $101 billion annually in diagnosis and treatment and ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Carter also said that the longer diabetics wait to get their eyes checked, the more at risk they are for potential eye-sight ...